One provocative article about reducing our reliance on foreign sources for drug development leads to some strange feedback, which leads to some additional intriguing articles.

Our guest Rob Wright talks about his conversations with a biotech startup that allowed him to review their pitch deck in preparation for some potential investor meetings.

Anna Rose Welch, Chief Editor of Biosimilar Development, discusses her foray into making videos for LinkedIn (along with her cat) and the state of the biosimilars industry, including some upcoming conferences.

Rob Wright, Chief Editor of Life Science Leader magazine, discusses the many changes that have occurred in his job and the jobs of some of our pharma subscribers due to the COVID-19 pandemic. He also discusses one reader’s unique idea regarding some inspiring stories that have cropped up during this current crisis. 

What has the coronavirus outbreak taught us about the pharmaceutical supply chain? A lot, and some of it’s not good, according to our guest today, Louis Garguilo, Chief Editor of Outsourced Pharma.

Bioprocess Online Chief Editor Matt Pillar gives some background on his provocative new article, “Is Biopharma's Response To Coronavirus Off The Mark?” He also discusses his feature story, “The Perilous Development of a Potential Biologic Blockbuster,” and why it’s one of the most read articles on his site. (For additional information on Life Science Connect and its network of online resources, visit Life Science Connect). 

Cell & Gene Chief Editor Erin Harris is the guest on the podcast today. She discusses some of the top names on her editorial advisory board and gives a glimpse into the 2020 outlook articles that the board has been authoring. 

On today’s episode of the Life Science Connect podcast, Clinical Leader Chief Editor Ed Miseta talks about a virtual conference on patient centricity called “Focus On Patients,” covering the successes and challenges of putting patients at the center of clinical trials.

In this episode, Life Science Leader magazine Chief Editor Rob Wright talks about what he learned while attending this year’s JPM Conference and some of the other peripheral life sciences events that go on in San Francisco during early January. He discusses some sessions he sat in, after-hours events he attended, and a few of the many executives he spoke with, some of whom will appear in future issues of the magazine.